LeaderPortfolio
Xiulian
Fan Xiulian
Rank #1767
CHINAHealthcarePharmaceuticals

Fan Xiulian

Net Worth
$2.36B
0% (24h)
Fan Xiulian, the CEO of Haisco Pharmaceutical Group, is a prominent figure in the healthcare industry, with an estimated net worth of $2 billion as of March 24, 2026. Her wealth stems from her success in the pharmaceuticals sector. Fan, along with partners, acquired the predecessor to Haisco in 2007 and took the company public in 2012. Haisco Pharmaceutical Group is known for its specialty pharmaceuticals, including those for anesthesia, oncology antiemetics, digestive care, antibiotics, and cardiovascular treatments. Fan Xiulian's leadership has been instrumental in the company's growth and its contribution to the pharmaceutical landscape.

The Full Dossier

Early Life and Education

Born in Mainland China in 1963, Fan Xiulian's early life and educational background remain less documented in readily available public sources. However, it is known that she is a graduate of Guangzhou's South China University of Technology.

Rise to Success

Fan Xiulian co-founded the precursor to Haisco Pharmaceutical Group with Wang Junmin in 2000. Her career trajectory led her to become the vice chairperson of Haisco in 2007. Fan, along with Wang Junmin and Zheng Wei, acquired the predecessor of Haisco in 2007 and took the company public on the Shenzhen Stock Exchange in 2012.

Key Business Strategies

Haisco Pharmaceutical Group, under Fan's leadership, focuses on research and development, bringing new pharmaceutical products to market. The company has invested in its R&D facilities. This focus has enabled Haisco to expand its product line and capitalize on the growing demand within the Chinese market, including an aging population.

Philanthropy

Information on Fan Xiulian's specific philanthropic activities is limited in the available search results.

Career Timeline

2012

Haisco IPO

Haisco Pharmaceutical Group went public on the Shenzhen Stock Exchange.

2007

Vice Chairperson of Haisco

Became vice chairperson of Xizang Haisco Pharmaceutical Group.

2000

Co-founded the precursor to Haisco

Co-founded the precursor to Haisco Pharmaceutical Group with Mr. Wang Junmin.

Philanthropic Impact

Corporate Social ResponsibilityInformation not available

Corporate Citizen Contributions to Tibet

Haisco has made contributions to Tibet.

Wealth Trajectory